Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

about

Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis.Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits

P2860

Q41500577-C1412AB9-CA64-4FF4-B4D3-46AACBCED995 Q58776750-74D6EBC0-0CBB-4549-9A3F-F451B5E73C4D

P2860

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

Item

http://www.wikidata.org/entity/Q39333577

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Non-alcoholic fatty liver disease-a chronic disease of the 21

@nl

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

@en

type

Item

label

Non-alcoholic fatty liver disease-a chronic disease of the 21

@nl

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

@en

altLabel

Non-alcoholic fatty liver disease--a chronic disease of the 21 st century

@en

prefLabel

Non-alcoholic fatty liver disease-a chronic disease of the 21

@nl

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

@en

P1476

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

@en

P2093

Metrakos Peter

http://www.w3.org/2001/XMLSchema#string

Nilsson Tommy

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Autophagy: a new target for nonalcoholic fatty liver disease therapy

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

Crystal structure of the predicted phospholipase LYPLAL1 reveals unexpected functional plasticity despite close relationship to acyl protein thioesterases

Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

P304

327-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7555/JBR.31.20160153

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550272

http://www.w3.org/2001/XMLSchema#string

P932

6163117

http://www.w3.org/2001/XMLSchema#string

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

about

P2860

P2860

Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932